United Kingdom· GB-APID-39885811000001108
Byfavo 20mg powder for solution for injection vials
A remimazolam product containing remimazolam, registered in United Kingdom by PAION Pharma GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Remimazolam is registered in 14 of 19 countries.
Countries holding a registration under ATC N05CD14 (remimazolam), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Remimazolam · ATC N05CD14
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Remimazolam
- Manufacturer
- PAION Pharma GmbH
- Country
- United Kingdom (GB)
- ATC code
- N05CD14
- ATC class
- Remimazolam
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin08720256880035
- gtin08720256880004
- gtin04260727580100
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
71 interactions on record for remimazolam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Remimazolam · interactions on record
71 records
- 4 severe
- 64 moderate
- 3 minor
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Remimazolam in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayByfavoPAION Pharma GmbH
- BelgiumByfavo 20 mgPaion Pharma
- CzechiaBYFAVOPAION Pharma GmbH, Aachen
- SpainBYFAVO 20 MG POLVO PARA SOLUCION INYECTABLEPaion Pharma Gmbh
- PolandByfavoPAION Deutschland GmbH
- SwedenByfavo 20 mg Pulver till injektionsvätska, lösningPAION Pharma GmbH
- FinlandByfavoPAION Pharma GmbH
- Japanレミマゾラムベシル酸塩ムンディファーマ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Byfavo
- Liechtenstein · Byfavo
- Norway · Byfavo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/72d9ba03-e2b1-4b76-a8d7-017ada75d12c GET /v1/drugs/72d9ba03-e2b1-4b76-a8d7-017ada75d12c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39885811000001108",
"desc": "Byfavo 20mg powder for solution for injection vials (PAION Pharma GmbH)",
"form": "Powder for solution for injection",
"vpid": "39945111000001100",
"source": "dmd",
"vtm_id": "926384007",
"strength": "20 mg",
"substance": "Remimazolam",
"ingredient": "Remimazolam besylate",
"supplier_code": "39862411000001101"
}See everything about remimazolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.